ghk-cu copper peptide clinical studies trial injection (GHK-Cu): Clinical Uses, Stability & Compounding Tips Copper peptide (GHK-Cu) | SIELC

Continuous use makes sense for users still experiencing ongoing improvements without plateau suggesting continued benefit from sustained application, highly satisfied with current results wanting to maintain peak benefits without decline risk, financially comfortable with indefinite product investment as skincare priority, psychologically comfortable with long-term commitment to effective treatment, experiencing rapid benefit decline during previous break attempts indicating necessity of ongoing application, and prioritizing maximum results over cost optimization or flexibility concerns

No standardised endpoint

See published BPC-157 research at PubMed PMID 30213055

(1) Each bottle delivers 2400mg of GHK-Cu and 2400mg of AHK-Cu in a 1:1 ratio, using only distilled water and the two peptides